Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Document › Details

AvroBio, Inc.. (3/25/19). "Press Release: AvroBio, Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update". Cambridge, MA.

	Organisation	AvroBio Inc. (Nasdaq: AVRO)
	Group	AvroBio (Group)
	Organisation 2	University of California, San Diego (UCSD)
	Group	University of California (System)
	Product	AVR-RD-01 gene therapy (AvroBio)
	Product 2	DRUGS, ORPHAN
	Person	MacKay, Geoff (AvroBio 201703 CEO)
	Person 2	Morris, Kathryn (Yates Network 201909)

Original document
accessed by [iito] on 2019-10-22

Record changed: 2023-06-05

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for AvroBio (Group)

[1] AvroBio, Inc.. (5/22/23). "Press Release: AvroBio Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million". Cambridge, MA....
[2] AvroBio, Inc.. (7/19/19). "Press Release: AvroBio Announces Closing of Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridge, MA....
[3] AvroBio, Inc.. (12/19/18). "Press Release: AvroBio Receives Orphan-Drug Designation from the U.S. FDA for AVR-RD-01 for the Treatment of Fabry Disease". Cambridge, MA....
[4] AvroBio, Inc.. (12/18/18). "Press Release: AvroBio, Inc. Expands and Strengthens Leadership Team with Four Senior Management Hires". Cambridge, MA....
[5] AvroBio, Inc.. (6/27/18). "Press Release: AvroBio, Inc. Appoints Phillip B. Donenberg to Its Board of Directors". Cambridge, MA....
[6] AvroBio, Inc.. (6/25/18). "Press Release: AvroBio, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Overallotment Option". Cambridge, MA....
[7] AvroBio, Inc.. (6/20/18). "Press Release: AvroBio, Inc. Announces Pricing of Initial Public Offering". Cambridge, MA....
[8] AvroBio, Inc.. (4/4/18). "Press Release: AvroBio, Inc. Appoints Annalisa Jenkins to Its Board of Directors". Cambridge, MA....
[9] AvroBio, Inc.. (2/1/18). "Press Release: AvroBio, Inc. Announces $60 Million Series B Financing to Advance Gene Therapy Pipeline for Lysosomal Storage Disorders and Apply Lentiviral Platform to Other Genetic Diseases". Cambridge, MA....
[10] AvroBio, Inc.. (11/9/17). "Press Release: AvroBio, Inc. Appoints Ian Clark to Its Board of Directors". Cambridge, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]